Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thai Meiji Pharmaceutical is a prominent pharmaceutical manufacturer based in Thailand and a key subsidiary of Japan's Meiji Seika Pharma. Established in 1979 as a joint venture, the company has grown into a major regional hub for the production and distribution of human and veterinary medicines. Its core expertise lies in the manufacturing of high-quality antibiotics, including flagship brands such as Meiact and Fosmicin. The company operates a state-of-the-art manufacturing facility in the Lad Krabang Industrial Estate that adheres to international Good Manufacturing Practice (GMP) standards. In addition to its own product portfolio, Thai Meiji provides contract manufacturing services and distributes specialty chemicals across Southeast Asia. The organization is dedicated to improving regional healthcare through the supply of essential anti-infective therapies and animal health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thai Meiji Pharmaceutical.